Details
Stereochemistry | ABSOLUTE |
Molecular Formula | 2C18H21NO3.H2O.2H3O4P |
Molecular Weight | 812.7341 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 10 / 10 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.OP(O)(O)=O.OP(O)(O)=O.[H][C@@]12OC3=C4C(C[C@H]5N(C)CC[C@@]14[C@@]5([H])C=C[C@@H]2O)=CC=C3OC.[H][C@@]67OC8=C9C(C[C@H]%10N(C)CC[C@@]69[C@@]%10([H])C=C[C@@H]7O)=CC=C8OC
InChI
InChIKey=DKSZLDSPXIWGFO-BLOJGBSASA-N
InChI=1S/2C18H21NO3.2H3O4P.H2O/c2*1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19;2*1-5(2,3)4;/h2*3-6,11-13,17,20H,7-9H2,1-2H3;2*(H3,1,2,3,4);1H2/t2*11-,12+,13-,17-,18-;;;/m00.../s1
Codeine is an opiate used to manage mild to moderate pain severe enough to require an opioid. Codeine is a selective agonist for the mu opioid receptor and has an affinity to delta and kappa-opioid receptors. In some countries, this drug is regulated under various narcotic control laws, because its chronic use can cause physical dependence. In others, it is available without a medical prescription in combination with paracetamol.
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL233 |
6.1 µM [EC50] | ||
Target ID: P41145 Gene ID: 4986.0 Gene Symbol: OPRK1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/7885194 |
|||
Target ID: P41143 Gene ID: 4985.0 Gene Symbol: OPRD1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/7885194 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | CAPITAL AND CODEINE Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Over-the-counter medications for acute cough in children and adults in ambulatory settings. | 2001 |
|
Dystonia as acute adverse reaction to cough suppressant in a 3-year-old girl. | 2001 |
|
Sticky business: patterns of procurement and misuse of prescription cough syrup in Houston. | 2001 Apr-Jun |
|
Randomized placebo controlled trial of lofexidine hydrochloride for chronic pelvic pain in women. | 2001 Aug |
|
Simultaneous determination of codeine and ethyl morphine HCL in tablet formulations using LC. | 2001 Aug |
|
Prescribing limitations. | 2001 Aug 11 |
|
Precipitated withdrawal following codeine administration is dependent on CYP genotype. | 2001 Aug 17 |
|
[Paracetamol-codeine induced hepatic colic]. | 2001 Aug-Sep |
|
LC method for the analysis of paracetamol, caffeine and codeine phosphate in pharmaceutical preparations. | 2001 Dec |
|
Effect of penicillin on postoperative endodontic pain and swelling in symptomatic necrotic teeth. | 2001 Feb |
|
Effect of prophylactic amoxicillin on endodontic flare-up in asymptomatic, necrotic teeth. | 2001 Jan |
|
Opiate-sensitivity: clinical characteristics and the role of skin prick testing. | 2001 Jul |
|
Contribution of dihydrocodeine and dihydromorphine to analgesia following dihydrocodeine administration in man: a PK-PD modelling analysis. | 2001 Jul |
|
Head-column field-amplified sample stacking in presence of siphoning. Application to capillary electrophoresis-electrospray ionization mass spectrometry of opioids in urine. | 2001 Jul 27 |
|
Use of beta-cyclodextrin in the capillary zone electrophoretic separation of the components of clandestine heroin preparations. | 2001 Jul 27 |
|
Heroin use by motorists in Sweden confirmed by analysis of 6-acetylmorphine in urine. | 2001 Jul-Aug |
|
Laboratory analysis of remotely collected oral fluid specimens for opiates by immunoassay. | 2001 Jul-Aug |
|
[Chronic pain in geriatrics]. | 2001 Jun |
|
Effect of apical trephination on postoperative pain and swelling in symptomatic necrotic teeth. | 2001 Jun |
|
[Information on preparations containing codeine]. | 2001 Jun 20 |
|
Codeine phosphate in paediatric medicine. | 2001 Mar |
|
Codeine phosphate in children: time for re-evaluation? | 2001 Mar |
|
From codeine to transdermal fentanyl for cancer pain control: a safety and efficacy clinical trial. | 2001 May-Jun |
|
Scalp nerve blocks decrease the severity of pain after craniotomy. | 2001 Nov |
|
Concentration ratios of morphine to codeine in blood of impaired drivers as evidence of heroin use and not medication with codeine. | 2001 Nov |
|
The role of adrenal corticosteroids in induction of micronuclei by morphine. | 2001 Nov 15 |
|
Nutritional effects of surgical and medical treatment for short bowel syndrome. | 2001 Nov-Dec |
|
Novel dynamic polymer coating for capillary electrophoresis in nonaqueous methanolic background electrolytes. | 2001 Oct |
|
Seizures with intravenous codeine phosphate. | 2001 Oct |
|
Incorporation of selegiline metabolites into hair after oral selegiline intake. | 2001 Oct |
|
Analysis of morphine and codeine in samples adulterated with Stealth. | 2001 Oct |
|
Detection of opiate use in a methadone maintenance treatment population with the CEDIA 6-acetylmorphine and CEDIA DAU opiate assays. | 2001 Oct |
|
Ropivacaine with or without clonidine improves pediatric tonsillectomy pain. | 2001 Oct |
|
Drug contamination of US paper currency. | 2001 Oct 1 |
|
Predictors for completing an inpatient detoxification program among intravenous heroin users, methadone substituted and codeine substituted patients. | 2001 Oct 1 |
|
Endogenous morphine and codeine. Possible role as endogenous anticonvulsants. | 2001 Oct 12 |
|
Spontaneous reports on drug-induced pancreatitis in Denmark from 1968 to 1999. | 2001 Sep |
|
Community pharmacists' experience of over-the-counter medicine misuse in Scotland. | 2001 Sep |
|
Cetirizine inhibits skin reactions but not mediator release in immediate and developing late-phase allergic cutaneous reactions. A double-blind, placebo-controlled study. | 2001 Sep |
|
Rofecoxib versus codeine/acetaminophen in postoperative dental pain: a double-blind, randomized, placebo- and active comparator-controlled clinical trial. | 2001 Sep |
|
Tramadol/acetaminophen combination tablets and codeine/acetaminophen combination capsules for the management of chronic pain: a comparative trial. | 2001 Sep |
|
Blind trials of an onsite saliva drug test for marijuana and opiates. | 2001 Sep |
|
[Weak opioids]. | 2001 Sep |
|
[Strong opioids]. | 2001 Sep |
|
Concentration ratios of codeine-to-morphine in plasma after a single oral dose (100 mg) of codeine phosphate. | 2001 Sep |
|
Detection of non-prescription heroin markers in urine with liquid chromatography-atmospheric pressure chemical ionization mass spectrometry. | 2001 Sep |
|
Pain control in medical abortion. | 2001 Sep |
|
Engineering novel biocatalytic routes for production of semisynthetic opiate drugs. | 2001 Sep |
|
Can standard open pediatric urological procedures be performed on an outpatient basis? | 2001 Sep |
|
Experience with urine drug testing by the Correctional Service of Canada. | 2001 Sep 15 |
Sample Use Guides
In Vivo Use Guide
Sources: https://online.lexi.com/lco/medguides/622452.pdf
Unknown
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 1308.15
Created by
admin on Fri Dec 15 15:09:33 GMT 2023 , Edited by admin on Fri Dec 15 15:09:33 GMT 2023
|
||
|
CFR |
21 CFR 290.2
Created by
admin on Fri Dec 15 15:09:33 GMT 2023 , Edited by admin on Fri Dec 15 15:09:33 GMT 2023
|
||
|
NCI_THESAURUS |
C1657
Created by
admin on Fri Dec 15 15:09:33 GMT 2023 , Edited by admin on Fri Dec 15 15:09:33 GMT 2023
|
||
|
DEA NO. |
9050
Created by
admin on Fri Dec 15 15:09:33 GMT 2023 , Edited by admin on Fri Dec 15 15:09:33 GMT 2023
|
||
|
CFR |
21 CFR 341.14
Created by
admin on Fri Dec 15 15:09:33 GMT 2023 , Edited by admin on Fri Dec 15 15:09:33 GMT 2023
|
||
|
CFR |
21 CFR 341.74
Created by
admin on Fri Dec 15 15:09:33 GMT 2023 , Edited by admin on Fri Dec 15 15:09:33 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB29134
Created by
admin on Fri Dec 15 15:09:33 GMT 2023 , Edited by admin on Fri Dec 15 15:09:33 GMT 2023
|
PRIMARY | |||
|
DTXSID20904612
Created by
admin on Fri Dec 15 15:09:33 GMT 2023 , Edited by admin on Fri Dec 15 15:09:33 GMT 2023
|
PRIMARY | |||
|
DBSALT000030
Created by
admin on Fri Dec 15 15:09:33 GMT 2023 , Edited by admin on Fri Dec 15 15:09:33 GMT 2023
|
PRIMARY | |||
|
100000090188
Created by
admin on Fri Dec 15 15:09:33 GMT 2023 , Edited by admin on Fri Dec 15 15:09:33 GMT 2023
|
PRIMARY | |||
|
6321303
Created by
admin on Fri Dec 15 15:09:33 GMT 2023 , Edited by admin on Fri Dec 15 15:09:33 GMT 2023
|
PRIMARY | |||
|
C74548
Created by
admin on Fri Dec 15 15:09:33 GMT 2023 , Edited by admin on Fri Dec 15 15:09:33 GMT 2023
|
PRIMARY | |||
|
1144000
Created by
admin on Fri Dec 15 15:09:33 GMT 2023 , Edited by admin on Fri Dec 15 15:09:33 GMT 2023
|
PRIMARY | |||
|
41444-62-6
Created by
admin on Fri Dec 15 15:09:33 GMT 2023 , Edited by admin on Fri Dec 15 15:09:33 GMT 2023
|
PRIMARY | |||
|
CHEMBL485
Created by
admin on Fri Dec 15 15:09:33 GMT 2023 , Edited by admin on Fri Dec 15 15:09:33 GMT 2023
|
PRIMARY | |||
|
2672
Created by
admin on Fri Dec 15 15:09:33 GMT 2023 , Edited by admin on Fri Dec 15 15:09:33 GMT 2023
|
PRIMARY | RxNorm | ||
|
CODEINE PHOSPHATE
Created by
admin on Fri Dec 15 15:09:33 GMT 2023 , Edited by admin on Fri Dec 15 15:09:33 GMT 2023
|
PRIMARY | Description: Small, colourless crystals or a white, crystalline powder; odourless.Solubility: Soluble in 4 parts of water; slightly soluble in ethanol (~750 g/l) TS; practically insoluble in ether R.Category: Antitussive; analgesic.Storage: Codeine phosphate should be kept in a tightly closed container, protected from light.Labelling: The designation on the container should state if the Codeine phosphate is the hemihydrate or the sesquihydrate.Additional information. Codeine phosphate effloresces in dry air. | ||
|
GSL05Y1MN6
Created by
admin on Fri Dec 15 15:09:33 GMT 2023 , Edited by admin on Fri Dec 15 15:09:33 GMT 2023
|
PRIMARY | |||
|
GSL05Y1MN6
Created by
admin on Fri Dec 15 15:09:33 GMT 2023 , Edited by admin on Fri Dec 15 15:09:33 GMT 2023
|
PRIMARY | |||
|
SUB13428MIG
Created by
admin on Fri Dec 15 15:09:33 GMT 2023 , Edited by admin on Fri Dec 15 15:09:33 GMT 2023
|
PRIMARY | |||
|
SUB13427MIG
Created by
admin on Fri Dec 15 15:09:33 GMT 2023 , Edited by admin on Fri Dec 15 15:09:33 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD